PUBLISHER: QYResearch | PRODUCT CODE: 1099264
PUBLISHER: QYResearch | PRODUCT CODE: 1099264
Due to the COVID-19 pandemic, the global Hemoperfusion Cartridge market size is estimated to be worth US$ 816.44 million in 2022 and is forecast to a readjusted size of US$ 2072.84 million by 2028 with a CAGR of 16.80% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Resin Adsorption accounting for 88.46% of the Hemoperfusion Cartridge global market in 2021, is projected to value US$ 1842.13 million by 2028, growing at a revised 16.89% CAGR from 2022 to 2028. While Hospital segment is altered to an 16.89% CAGR throughout this forecast period.
China Hemoperfusion Cartridge market size was US$ 356.39 million in 2021, while the Japan and Europe Hemoperfusion Cartridge were US$ 168.64 million and US$ 79.61 million, severally. The proportion of the China was 48.80% in 2021, while Japan and Europe are 23.09% and 10.90% respectively, and it is predicted that China proportion will reach 47.54% in 2028, trailing a CAGR of 16.61% through the analysis period. Japan, South Korea, and Vietnam are noteworthy markets in Asia, with CAGR 16.34%, 17.65%, and 16.64% respectively for the next 6-year period. As for the Europe Hemoperfusion Cartridge landscape, Germany is projected to reach US$ 81.86 million by 2028 trailing a CAGR of 18.29% over the forecast period.
The global key manufacturers of Hemoperfusion Cartridge include Baxter International, Jafron Biomedical, Asahi Kasei Corporation, Toray Medical, Kaneka Medix Corporation, Baihe Medical and CytoSorbents, etc. In 2021, the global top five players hold a share approximately 92.17% in terms of revenue.
Hemoperfusion Cartridge market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hemoperfusion Cartridge market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.